PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation.

Regenerated cartilage formed after Autologous Chondrocyte Implantation may be of suboptimal quality due to postulated hypertrophic changes. Parathyroid hormone-related peptide, containing the parathyroid hormone sequence (PTHrP 1-34), enhances cartilage growth during development and inhibits hypertr...

Full description

Bibliographic Details
Main Authors: Marijn Rutgers, Frances Bach, Luciënne Vonk, Mattie van Rijen, Vanessa Akrum, Antonette van Boxtel, Wouter Dhert, Laura Creemers
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0213483
id doaj-d62d1d739ab04fb888f101b54f526784
record_format Article
spelling doaj-d62d1d739ab04fb888f101b54f5267842021-03-03T20:45:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01144e021348310.1371/journal.pone.0213483PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation.Marijn RutgersFrances BachLuciënne VonkMattie van RijenVanessa AkrumAntonette van BoxtelWouter DhertLaura CreemersRegenerated cartilage formed after Autologous Chondrocyte Implantation may be of suboptimal quality due to postulated hypertrophic changes. Parathyroid hormone-related peptide, containing the parathyroid hormone sequence (PTHrP 1-34), enhances cartilage growth during development and inhibits hypertrophic differentiation of mesenchymal stromal cells (MSCs) and growth plate chondrocytes. This study aims to determine the possible anabolic and/or hypertrophic effect of PTH on human articular chondrocytes. Healthy human articular cartilage-derived chondrocytes (n = 6 donors) were cultured on type II collagen-coated transwells with/without 0.1 or 1.0 μM PTH from day 0, 9, or 21 until the end of culture (day 28). Extracellular matrix production, (pre)hypertrophy and PTH signaling were assessed by RT-qPCR and/or immunohistochemistry for collagen type I, II, X, RUNX2, MMP13, PTHR1 and IHH and by determining glycosaminoglycan production and DNA content. The Bern score assessed cartilage quality by histology. Regardless of the concentration and initiation of supplementation, PTH treatment significantly decreased DNA and glycosaminoglycan content and reduced the Bern score compared with controls. Type I collagen deposition was increased, whereas PTHR1 expression and type II collagen deposition were decreased by PTH supplementation. Expression of the (pre)hypertrophic markers MMP13, RUNX2, IHH and type X collagen were not affected by PTH. In conclusion, PTH supplementation to healthy human articular chondrocytes did not affect hypertrophic differentiation, but negatively influenced cartilage quality, the tissues' extracellular matrix and cell content. Although PTH may be an effective inhibitor of hypertrophic differentiation in MSC-based cartilage repair, care may be warranted in applying accessory PTH treatment due to its effects on articular chondrocytes.https://doi.org/10.1371/journal.pone.0213483
collection DOAJ
language English
format Article
sources DOAJ
author Marijn Rutgers
Frances Bach
Luciënne Vonk
Mattie van Rijen
Vanessa Akrum
Antonette van Boxtel
Wouter Dhert
Laura Creemers
spellingShingle Marijn Rutgers
Frances Bach
Luciënne Vonk
Mattie van Rijen
Vanessa Akrum
Antonette van Boxtel
Wouter Dhert
Laura Creemers
PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation.
PLoS ONE
author_facet Marijn Rutgers
Frances Bach
Luciënne Vonk
Mattie van Rijen
Vanessa Akrum
Antonette van Boxtel
Wouter Dhert
Laura Creemers
author_sort Marijn Rutgers
title PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation.
title_short PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation.
title_full PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation.
title_fullStr PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation.
title_full_unstemmed PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation.
title_sort pth decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2019-01-01
description Regenerated cartilage formed after Autologous Chondrocyte Implantation may be of suboptimal quality due to postulated hypertrophic changes. Parathyroid hormone-related peptide, containing the parathyroid hormone sequence (PTHrP 1-34), enhances cartilage growth during development and inhibits hypertrophic differentiation of mesenchymal stromal cells (MSCs) and growth plate chondrocytes. This study aims to determine the possible anabolic and/or hypertrophic effect of PTH on human articular chondrocytes. Healthy human articular cartilage-derived chondrocytes (n = 6 donors) were cultured on type II collagen-coated transwells with/without 0.1 or 1.0 μM PTH from day 0, 9, or 21 until the end of culture (day 28). Extracellular matrix production, (pre)hypertrophy and PTH signaling were assessed by RT-qPCR and/or immunohistochemistry for collagen type I, II, X, RUNX2, MMP13, PTHR1 and IHH and by determining glycosaminoglycan production and DNA content. The Bern score assessed cartilage quality by histology. Regardless of the concentration and initiation of supplementation, PTH treatment significantly decreased DNA and glycosaminoglycan content and reduced the Bern score compared with controls. Type I collagen deposition was increased, whereas PTHR1 expression and type II collagen deposition were decreased by PTH supplementation. Expression of the (pre)hypertrophic markers MMP13, RUNX2, IHH and type X collagen were not affected by PTH. In conclusion, PTH supplementation to healthy human articular chondrocytes did not affect hypertrophic differentiation, but negatively influenced cartilage quality, the tissues' extracellular matrix and cell content. Although PTH may be an effective inhibitor of hypertrophic differentiation in MSC-based cartilage repair, care may be warranted in applying accessory PTH treatment due to its effects on articular chondrocytes.
url https://doi.org/10.1371/journal.pone.0213483
work_keys_str_mv AT marijnrutgers pthdecreasesinvitrohumancartilageregenerationwithoutaffectinghypertrophicdifferentiation
AT francesbach pthdecreasesinvitrohumancartilageregenerationwithoutaffectinghypertrophicdifferentiation
AT luciennevonk pthdecreasesinvitrohumancartilageregenerationwithoutaffectinghypertrophicdifferentiation
AT mattievanrijen pthdecreasesinvitrohumancartilageregenerationwithoutaffectinghypertrophicdifferentiation
AT vanessaakrum pthdecreasesinvitrohumancartilageregenerationwithoutaffectinghypertrophicdifferentiation
AT antonettevanboxtel pthdecreasesinvitrohumancartilageregenerationwithoutaffectinghypertrophicdifferentiation
AT wouterdhert pthdecreasesinvitrohumancartilageregenerationwithoutaffectinghypertrophicdifferentiation
AT lauracreemers pthdecreasesinvitrohumancartilageregenerationwithoutaffectinghypertrophicdifferentiation
_version_ 1714820827123286016